Stereotaxis Announces Definitive Agreement to Acquire Robocath - The Manila Times

Stereotaxis has acquired Robocath, a medical devices business in France. Robocath designs and develops robotic-assisted catheter navigation systems used in interventional cardiology and electrophysiology procedures, supporting precise placement during complex treatments. Stereotaxis acquisitions in healthcare M&A aim to expand its portfolio of image-guided and robotic solutions for hospitals and clinics, strengthening adoption of advanced cardiac intervention technologies. The strategic acquisition was announced as a definitive agreement, with deal size undisclosed, and is expected to close subject to customary conditions.